MedPath

浙江普洛康裕制药有限公司

Ownership
-
Established
1995-08-08
Employees
-
Market Cap
-
Website
http://www.apeloa.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

124

NMPA:124

Drug Approvals

Oseltamivir Phosphate Capsules

Product Name
磷酸奥司他韦胶囊
Approval Number
国药准字H20249658
Approval Date
Dec 1, 2024
NMPA

Ademetionine Butanedisulfonate for Injection

Product Name
注射用丁二磺酸腺苷蛋氨酸
Approval Number
国药准字H20249311
Approval Date
Nov 15, 2024
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20247277
Approval Date
Nov 7, 2024
NMPA

Ademetionine 1,4-Butanedisulfonate Enteric Coated Tablets

Product Name
丁二磺酸腺苷蛋氨酸肠溶片
Approval Number
国药准字H20249303
Approval Date
Nov 5, 2024
NMPA

Bupropion Hydrochloride Sustained-release Tablets (Ⅱ)

Product Name
盐酸安非他酮缓释片(Ⅱ)
Approval Number
国药准字H20247260
Approval Date
Oct 29, 2024
NMPA

麦味地黄口服液

Approval Number
国药准字Z33020627
Approval Date
Sep 30, 2024
NMPA

Levetiracetam Tablets

Product Name
左乙拉西坦片
Approval Number
国药准字H20193257
Approval Date
Aug 9, 2024
NMPA

Levetiracetam Tablets

Product Name
左乙拉西坦片
Approval Number
国药准字H20193256
Approval Date
Aug 9, 2024
NMPA

Fleroxacin Injection

Product Name
氟罗沙星注射液
Approval Number
国药准字H20084351
Approval Date
Mar 18, 2024
NMPA

Bupropion Hydrochloride Sustained-release Tablets (Ⅱ)

Product Name
盐酸安非他酮缓释片(Ⅱ)
Approval Number
国药准字H20234194
Approval Date
Sep 28, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.